1
Investors
About
PhotoPharmics is a clinical-stage medical device company developing non-invasive photo-neuromodulation therapies targeting retinal and circadian signaling pathways to address unmet needs in Parkinson's disease.
Explore PhotoPharmics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.